Company intelligence / Profile preview

Aplitech

Guangzhou, Guangdong, Chinajaimecamil.com ↗

Ownership: Private
Development stage: Other

Overview

Applitech is a leading Chinese high-tech company specializing in the design, R&D, production, sales, and service of bioreactors and related equipment for the biopharmaceutical industry. The company’s products support research through commercial-scale manufacturing of biologics including antibodies, vaccines, cell therapies, gene therapies and stem cell therapies. It was recently recognized as a Guangdong Provincial Enterprise Technology Center for its innovation capabilities.

Therapeutic areas: Other
Modalities: Cell therapyGene therapyAntibodyVaccineStem cell therapy
Industry: Non-Drug Biotech

Partnerships

InnoCellular Tech Pte Ltd (Singapore): Partnership to accelerate next-generation cell therapy advancements in Asia by integrating advanced bioreactor systems with specialized cell culture media

Beyond the preview

Go deeper on Aplitech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aplitech.

Explore the full profile